Non-squamous cell carcinoma of head and neck
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: A) Non-squamous cell carcinoma of head and neck which is pathologically or cytologically diagnosed, except for malignant melanoma and sarcoma B) Patient without lymph node metastasis or with clinical stage of N1 which can be treated by the same irradiation field as primary lesion C) Measurable primary lesion D) No remote metastasis E) 0 to 2 of performance status F) 15 years or older and 80 years or younger of age, and 6 months or longer of expected survival G) Patient is able to understand this clinical trial and is informed for the diagnosis and disease status. And patient can be given consent with document after explanation of this trial by study personnel
Exclusion criteria
Exclusion criteria: A) Past history of radiotherapy for the target lesion B) Less than two weeks after the last administration of chemotherapy C) Active double cancer D) Active and intractable infection in the target lesion E) Metal devices in the target lesion which is not able to be removed F) Patient is not suitable for this study due to medical, psychological or the other reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Local control rate at 3 years | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Overall survival, Disease-specific survival 2) Early and late adverse event rate 3) Local response rate (primary treatment outcome) | — |
Countries
Japan
Contacts
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organizatio Ion-beam Radiation Oncology Center